學 名              商品名         藥 廠                  種類

 Sunitinib             Sutent舒癌特          Pfizer 輝瑞藥 廠                 TKI

 Sorabenib            Nexavar蕾莎瓦       Bayer 拜耳                         TKI

 Everolimus          Afinitor 癌伏妥       Novartis 台灣諾華        mTOR inhibitor

Temsirolimus      Torisel 特癌適         Pfizer輝 瑞                    mTOR inhibitor

 Bevacizumab      Avastin 癌思停        Roche 羅氏台灣       anti- VEGF-A antibody

  Pazopanib           Votrient                   台灣尙未上市, GSK             TKI

 Future TKIs:

 Axitinib ( AG013736, phase III trial, Pfizer 輝瑞 )

Tivozanib (AV951, phase III trial, AVEO pharma)

Dovitinib (TKI 258, phase III trial, Novartis 諾華)

TKI= tyrosine kinase inhibitors